Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
26 hedge funds and large institutions have $2.63M invested in Streamline Health Solutions in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 8 closing their positions.
0.13% less ownership
Funds ownership: 1.33% → 1.2% (-0.13%)
13% less funds holding
Funds holding: 30 → 26 (-4)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
54% less capital invested
Capital invested by funds: $5.72M → $2.63M (-$3.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$55.6K |
| 2 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
+$32.5K |
| 3 |
Jane Street
New York
|
+$29.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.3K |
| 5 |
HF
HRT Financial
New York
|
+$9.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Herald Investment Management
London,
United Kingdom
|
-$393K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$58K |
| 3 |
AWM
Austin Wealth Management
Austin,
Texas
|
-$43.7K |
| 4 |
BlackRock
New York
|
-$26.3K |
| 5 |
Renaissance Technologies
New York
|
-$16.7K |
STRM Hedge Fund Activity: Q3 2024 in Review
26 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q3 2024, worth a combined $2.63M — down 54% from $5.72M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of STRM and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was UBS Group, adding an estimated $55.6K. The largest seller was Herald Investment Management, exiting entirely with an estimated $393K sold.
- 26 institutional investors held Streamline Health Solutions (STRM) as of Q3 2024, down from 30 in Q2 2024.
- Funds reported $2.63M of Streamline Health Solutions stock for Q3 2024, down 54% quarter-over-quarter.
- 4 funds opened new Streamline Health Solutions positions in Q3 2024 and 8 closed out, a net change of -4 holders.
- The largest Streamline Health Solutions buyer in Q3 2024 was UBS Group, an estimated $55.6K added.
- The largest Streamline Health Solutions seller in Q3 2024 was Herald Investment Management, an estimated $393K sold.
Based on aggregated 13F filings for Q3 2024.